Skip to main content
Clinical Trials/NL-OMON36101
NL-OMON36101RecruitingNot Applicable

ong term follow up of the clinical and immunological responses following HPV 16 E6/E7 synthetic long peptides vaccination in women with HPV 16 positive vulvar intraepithelial neoplasia grade 3 - Long term follow up of HPV 16 E6/E7 SLP vaccine in VIN 3 lesions

eids Universitair Medisch Centrum0 sites19 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
19

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients are eligible and will be included if they participated in the initial phase II study and provide informed consent for the current study.

Exclusion Criteria

  • There are no exclusion criteria for this follow up study.

Investigators

Similar Trials